Domov › Nemalicelični pljučni rak › Kalifornija › Fullerton

Klinične študije za Nemalicelični pljučni rak v Fullerton, CA

13 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Fullerton in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Vključevanje udeležencevFaza 1/2

Providence - St. Jude Medical Center /ID# 271414, Fullerton

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06772623

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Vključevanje udeležencevFaza 3

Providence St. Jude Medical Center ( Site 0106), Fullerton

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06623422

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center, Fullerton

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

Providence Medical Foundation, Fullerton

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06667076

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
Providence St. Jude Medical Center, Fullerton
in še 1

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Vključevanje udeležencevFaza 1/2

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
Providence St. Jude Medical Center, Fullerton

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07227298